![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/08 | (2006.01) |
A61K 47/38 | (2006.01) | ||
A61K 47/18 | (2017.01) | ||
A61K 31/46 | (2006.01) | ||
A61P 27/02 | (2006.01) |
(11) | Number of the document | 3548000 |
(13) | Kind of document | T |
(96) | European patent application number | 18798073.5 |
Date of filing the European patent application | 2018-05-10 | |
(97) | Date of publication of the European application | 2019-10-09 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
(46) | Date of publication of the claims translation | 2022-03-10 |
(86) | Number | PCT/US2018/032017 |
Date | 2018-05-10 |
(87) | Number | WO 2018/209051 |
Date | 2018-11-15 |
(30) | Number | Date | Country code |
201762505027 P | 2017-05-11 | US |
(72) |
PURI, Navneet , US
AKASAPU, Prem Sagar , US
MOHAMMED, Irfan A. , US
SOPPIMATH, Kumaresh , US
ILITCHEV, Iouri V. , US
ZHANG, Tao , US
|
(73) |
Vyluma Inc. ,
1019 US Highway 202-206, Bridgewater NJ 08807,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Atropino farmacinės kompozicijos |
ATROPINE PHARMACEUTICAL COMPOSITIONS |
Payment date | Validity (years) | Amount | |
2025-05-05 | 8 | 185.00 EUR |
2026-05-10 |